The Difference Between Biosimilars & Generic Drugs

GHAPPcast
08/08/2023 20 min Episodio 4
The Difference Between Biosimilars & Generic Drugs

Listen "The Difference Between Biosimilars & Generic Drugs"

Descargar episodio Ver en sitio original

Episode Synopsis

In the fourth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP  and guest Tedra Gray, NP discuss the differences between biosimilars and generic drugs.The learning objectives and goals for this episode are to:-Compare and contrast biosimilars and generics regarding:         -Molecular size and structure         -Complexity of development         -Cost of developmentPlease take our evaluation regarding this podcast here: https://www.ghapp.org/biosimilars-podcast-eval

More episodes of the podcast GHAPPcast

Medication Review: Resmetirom: Thyroid Hormone Receptor-β Agonism in MASH Treatment 13/01/2026
APP Roundtable: Approach To Starting Treatments in Patients With CHB 07/01/2026
APP Roundtable: Navigating Difficult Conversations in CHB 07/01/2026
APP Roundtable: Addressing Co-Morbidities in CHB 06/01/2026
FAQ: What Role Do NITs Play in Risk Stratification & Patient Selection—& Balancing Patient History? 06/01/2026
Journal Club: Review of Focused Recommendations for the Management of MASLD 16/12/2025
Medication Review: Resmetirom: Core Efficacy Data and Patient Selection Considerations 09/12/2025
FAQ: What Are The Functional And Prognostic Differences Between Fibrosis F3 And F4 Patients? 02/12/2025
The Conversation That Matters: Talking to Patients About Obesity and IMIDs 01/12/2025
From Insight to Action: Practical Strategies to Improve Outcomes in Patients with Obesity and IMIDs 24/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA